Meta analysis of the second collaborative study of Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC) in patients with stage II, estrogen-receptor-positive breast cancer

Breast Cancer

Volumn 4, Issue 2, 1997, Pages 93-101

  Yoshida, Minoru ^a   Abe, Osahiko ^b   Uchino, Junichi ^c   Kikuchi, Kaneo ^d   Abe, Rikiya ^e   Enomoto, Kohji ^f   Tominaga, Takeshi ^g   Fukami, Atsuo ^h   Sugimachi, Keizo ⁱ   Nomura, Yasuo ^j   Hattori, Takao ^k   Ogawa, Nobuya ^l  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d SENDAI CITY MEDICAL CENTER   (Japan)

^e FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^f KEIO UNIVERSITY   (Japan)

^g TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^h Kameda General Hospital   (Japan)

ⁱ KYUSHU UNIVERSITY   (Japan)

^j Department of Breast Surgery   (Japan)

^k HIROSHIMA UNIVERSITY   (Japan)

^l EHIME UNIVERSITY   (Japan)

more..

Author keywords

Breast cancer; Meta analysis; Postoperative adjuvant chemoendocrine therapy; Tamoxifen citrate; Tegafur (Futraful)

Indexed keywords

EID: 0002197805     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967062     Document Type: Article

References (29)

1. Rossi A, Bonadonna G, Valagussa P, et al: Multimodal treatment in operable breast cancer; Fiveyear results of the CMF programme. Br Med J 282:1427-1431, 1981. (Pubitemid 11096242)
2. Yoshimoto M, Kasumi F, Watanabe S, et al: Tenyear follow-up mitomycin C single agent adjuvant chemotherapy for breast cancer. In: Taguchi T, Andrysek O eds, New Trends in Cancer Chemotherapy with Mitomycin C, Excerpta Medica, Tokyo, pp58-67, 1987.
3. 1-(2'-furanidil) - 5-fluorouracil [FT-207]. Jpn J Cancer Clin 19:495-499, 1973 (in Japanese with English summary).
4. Ansfield FJ, Kallas GJ, Singson JP: Phase I-II studies of oral tegafur (Futraful). J Clin Oncol 1:107-110, 1983. (Pubitemid 14176798)
5. Adachi I: Clinical studies on the treatment of the patients with advanced breast cancer. Jpn J Cancer Chemother 21:72-78, 1981 (in Japanese with English summary). (Pubitemid 11045236)
6. Wada T, Koyama H, Nishizawa Y, et al: Chemoendocrine therapy for advanced breast cancer; A combined treatment with tamoxifen and FT-207. J Jpn Soc Cancer Ther 16:51-55, 1981 (in Japanese with English summary). (Pubitemid 11124048)
7. Abe O: The role of chemoendocrine agents in postoperative adjuvant therapy for breast cancer; Metaanalysis of the first collaborative studies of postoperative adjuvant chemoendocrine therapy for breast cancer (ACETBC). Breast Cancer 1:1-9, 1994.
8. Goldhirsch A: Meeting highlights; International panel on the treatment of primary breast cancer. JNCI 87:1441-1445, 1995.
9. Early Breast Cancer Trialists' Collaborative Group: Treatment of Early Breast Cancer, Vol 1; Worldwide Evidence 1985-1990. Oxford University Press, Oxford, pp12-19, 1990.
10. Sakamoto G: Characteristics and future prospect of breast cancer in Japan. Jpn J Breast Cancer 2:327-338, 1987 (in Japanese with English summary).
11. Baum M: Prospects for the future in the management of carcinoma of the breast; The biological fall out from clinical trials. In: Jones SE, Salmon SE eds, Adjuvant Therapy of Cancer IV, Groune & Stratton Inc, Orlando, pp321-329, 1984.
12. Tormy DC, Taylor SG, Kalish LA, et al: Adjuvant systemic therapy in premenopausal (CMF, CMFP, CMFPT) and postmenopausal (observation, CMFP, CMFPT) women with node positive breast cancer. In: Jones SE, Salmon SE eds, Adjuvant Therapy of Cancer IV, Groune & Stratton Inc, Orlando, pp359-368, 1984.
13. Fisher B: Treatment of primary breast cancer with L-PAM/5-FU and tamoxifen; An interim report. Breast Cancer Res Treat 3(Suppl 1):7-17, 1983. (Pubitemid 14127060)
14. Palshof T, Carstensen B, Mouridsen HT, et al: Reviews on Endocrine-Related. Cancer 17(Suppl):43-50, 1985.
15. Wallgren A, Baral E, Carstensen J, et al: Should adjuvant tamoxifen be given for several years in breast cancer? In: Jones SE, Salmon SE eds, Adjuvant Therapy of Cancer IV, Groune & Stratton Inc, Orlando, pp331-337, 1984.
16. Patterson JS, Battersby LA, Edwards DG: Review of the clinical pharmacology and international experience with tamoxifen in advanced breast cancer. In: Lacobelli S, et al eds, The Role of Tamoxifen in Breast Cancer, Raven Press, pp17-29, 1982.
17. Margreiter R, Wiegele J: Tamoxifen (Nolvadex) for premenopausal patients with advanced breast cancer. Breast Cancer Res Treat 4:45-48, 1984. (Pubitemid 14156405)
18. Tancini G, Bonadonna G, Valagussa P, et al: Adjuvant CMF in breast cancer; Comparative 5-year results of 12 versus 6 cycles. J Clin Oncol 1:2-10, 1983. (Pubitemid 13066135)
19. Smalley RV, Bartolucci AA, Moore M, et al: Southeastern Cancer Study Group: Breast cancer studies 1972-1982. Int J Radiat Oncol Biol Phys 9:1867-1874, 1983. (Pubitemid 14178667)
20. Brincker H, Mouridsen HT, Andersen KW: Adjuvant chemotherapy with cyclophosphamide or CMF in premenopausal woman with stage II breast cancer. Breast Cancer Res Treat 3:91-95, 1983. (Pubitemid 13102091)
21. Howell A, Bush H, George WD, et al: Controlled trial of adjuvant chemotherapy with cyclophosphamide, methotrexate, and fluorouracil for breast cancer. Lancet 2:307-311, 1984. (Pubitemid 14054817)
22. Nissen-Meyer R, Host H, Kjellgren K, et al: Scandinavian trials with short postoperative course versus a 12-cycle course. Recent Results Cancer Res 96:48-54, 1984.
23. Tormy DC, Weinberg VE, Holland JF, et al: A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer. J Clin Oncol 1:138-145, 1983. (Pubitemid 14176803)
24. Izuo M: Clinicopathological features of recurrent breast cancer. Jpn J Cancer Chem 12(Part I):412-420, 1985 (in Japanese with English summary).
25. Buyse M: Potential and pitfalls of randomized clinical trials in cancer research. Cancer Surv 8:91-105, 1989. (Pubitemid 20041139)
26. Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet 339:1-15, 71-85, 1992.
27. Nomura Y, Tominaga T, Adachi I, et al: Clinical evaluation of cyclophosphamide, methotrexate and 5 - fluorouracil (CMF) on advanced and recurrent breast cancer. Jpn J Cancer Chemother 21:1949-1956, 1994 (in Japanese with English summary). (Pubitemid 24314787)
28. Tormy C: Adjuvant systemic therapy in postoperative node-positive patients with breast carcinoma; The GALGB trial and ECOG premenopausal trial. Recent Results Cancer Res 96:153-165, 1984.
29. Yasumura T, Oka T, Honjo H: Menstrual abnormality in breast cancer patients receiving adjuvant endocrino-chemotherapy. Jpn J Cancer Chemother 15:2947-2952, 1988 (in Japanese with English summary). (Pubitemid 18259914)